*By Bridgette Webb*
Drugmaker Merck announced earlier this month it will slash prices on several drugs by 10 percent or more.
But there is a catch: the price rollback will only affect some of the smaller products in its portfolioーlike Hepatitis C drug, Zepatier, which accounts for about 4 percent of the company's salesーand not top sellers like cancer treatment Keytruda.
"Their scope is relatively limited," said Peter Loftus, a Reporter for the Wall Street Journal, during an interview on Cheddar Monday. "If you think about the total sales that Merck generatesーit's a relatively small percentage."
Merck's announcement was met with praise from the Trump administration. Health and Human Services Secretary Alex Azar claimed the drop in prices was spurred by Trump's latest crackdown on pharmaceutical companies.
Other big pharma names are following suit: Pfizer and Novartis announced they will freeze price increases for the rest of the year, earning them congratulatory tweets from the president.
Despite all of the price freezes and drops, Loftus says that patients may not actually see any real savings.
"I don't think you can say on a widespread basis, and really for the average drug or patient, that prices are coming down, there are still price increases."
For the full segment, [click here.]
(https://cheddar.com/videos/drugmakers-tout-lower-prices)
How Incorporating Resistance Bands Can Diversify Workout Sessions
A giant Tyrannosaurus rex skeleton that’s been dug up from three sites in the United States is going up for auction in Zurich. It's a first sale of its kind in Europe.
As the inaugural guest on Cheddar News' new show Be Well, Dr. Sandra Lee, also known as Dr. Pimple Popper, discussed when (and when not) to pop a pimple and how to take care of your skin and keep an eye out for signs of more dangerous issues such as cancer.
Moderna and Merck & Co. have developed a cancer vaccine that cuts the risk of death or recurrence of most deadly skin cancer by 44 percent compared to Keytruda on its own, according to researchers.
The company got the OK on Friday from the Federal Aviation Administration. CEO Elon Musk is giving 50-50 odds of Starship reaching orbit.
Vertical farming startup Babylon Micro-Farms recently raised $8 million in a Serie A round. Alexander Oleson, CEO and co-founder of Babylon Micro-Farms, joined Cheddar News to explain his company's mission to help businesses and communities grow their own fresh produce in a sustainable manner.
A new lab test can detect Parkinson's disease in its early stages.
Cheddar News is highlighting companies with a focus on sustainability for Earth Month. Ashley Allen, chief sustainability officer with Oatly, joined Cheddar News to discuss her company's mission to deliver products that have a minimal environmental impact. "We want to make it easy for people to eat better and live healthier lives without recklessly taxing the planet's resources," she said.
'Plant Kween' Talks Low Maintenance Care for Budding Plant Parents
The first image of a black hole captured in 2019 is getting a makeover. Researchers on Thursday revealed an updated version, which they made using artificial intelligence.
